Table 1:
Demographic and clinical features of the patients in this study
| Groups of patients | No of Cases, | Age mean,% | Age range | No. male/female | Proven IPA,% | Probable IPA,% | Possible IPA,% |
|---|---|---|---|---|---|---|---|
| Bone marrow transplant recipients | 18 | 33.4 | 14–57 | 11/7 | 5.5 | 22.2 | 33.3 |
| Patients with haematological malignancies | 24 | 38.3 | 15–72 | 17/7 | - | 25 | 46 |
| Solid organ transplant recipients* | 52 | 40.8 | 32–59 | 31/21 | 3.8 | 11.6 | 67.3 |
| Solid-organ cancer patients | 28 | 62.6 | 29–94 | 20/8 | - | 11 | 46 |
| Patients with autoimmune diseases and corticosteroids consumer | 43 | 42.8 | 15–79 | 18/25 | - | 7 | 35 |
| Patients in intensive care unit (ICU) | 29 | 47.3 | 18–81 | 17/12 | - | 6.9 | 34.5 |
| Patients with pulmonary and respiratory disorders ** | 206 | 54.5 | 7–86 | 120/86 | - | - | - |
IPA, invasive pulmonary aspergillosis
*
This group had also two patients with probable IFD (3.8%) (caused by Penicillium spp.)
**
Patients without the criteria of host factor: 2% positive direct examination + positive culture, 7.3% positive culture but with negative direct examination